Portfolio

The portfolio currently consists of around 59 companies. Four of these are listed on AIM, 1 on LSE and one on NASDAQ, the others are displayed by sector. Since 2000 around 5 companies a year have been added to the portfolio. If you would like to learn more about any of the companies in the current portfolio please contact us or refer to the linked company website addresses.

Diagnostics

Company Nature
CytoxPre-symptomatic diagnosis of Alzheimer's Disease
Oxford BiodynamicsDetection of aberrant gene expression (prognosis and diagnosis)
Oxford Cancer BiomarkersApplication of Cancer-Nav screen for stratification of patients
Oxford MedistressObjective, quantitive measurement of stress
Perspectum DiagnosticsA new scan technology that uses standard MRI technology and costs half as much as a biopsy

Med tech

Company Nature
Eykona3-D imaging medical device for use in wound care
Intelligent Ultrasound3D Fusion Ultrasound technology platform software solution providing enhanced image quality and a wider field of view.
OrganoxPortable device to preserve livers for transplantation for up to 3 days
Oxehealth LtdNovel technology enabling a digital camera to monitor the vital of patients in artificial light, without the need for any additional hardware.
Oxford BiomaterialsVariety of applications derived from knowledge of the nature of spider silk
OxSonicsOxSonics “UltraSpine” product provides a novel method of intervertebral disc repair, by enabling a minimally-invasive alternative to highly-invasive spinal fusion and disc replacement procedures.
OxtoxCost-effective technology to rapidly detect whether a person is currently 'under the influence' of specific drugs (initially cannabis)
OxtexManufactures of anisotropic self-inflating tissue expanders
Particle TherapeuticsNeedleless delivery of therapeutic molecules across the skin

Pharma Tools and Services

Company Nature
AuroxConfocal microscope products and pathology slide scanner technology
CrysalinAnalysis of protein structures for proteins which cannot be easily crystallised
InhiboxVirtual screening of molecules against protein targets
Oxford Gene TechnologyVarious services related to drug discovery and diagnosis(based on microarrays)
Oxford Nanopore TechnologiesNovel DNA sequencing technology
ZyoxelCommercialising microbioreactor technology to improve drug discovery and stem cell culture
back to top

Drug Discovery

Company Nature
AdaptimmuneT cell therapy to treat cancer and infectious diseases
Atopix Therapeuticsdeveloping anti-inflammatory medicines to treat asthma and other chronic allergic conditions
CelleronDeveloping targeted cancer medicines
ChronosDeveloping novel proprietary drugs with specific therapeutic effects on newly discovered biological mechanisms of age related diseases
ImmunocoreT cell receptor technology platform to treat cancer and viral diseases
Oxford VacmedixOverlapping peptide vaccines using a natural expression system
OxagenDiscovery of novel drugs for inflammatory diseases (lead programme based on GPCR receptor / asthma)
PharminoxDiscovery of small molecule anti-cancer drugs
ReOxTreatments for disease by modifying the effects of hypoxia
RiotechTherapeutics for viral hepatitis
SibeliusSibelius develops its own proprietary products and assists its partners in developing their nutraceutical and cosmeceutical product lines, all with the distinct activity of extension of cellular chronological lifespan.

Other Health Care

Company Nature
C-medCRO supporting services with comprehensive information and data systems
OBS MedicalDevelopment of a range of patient monitoring technology and software
OxitecEffective and environment-friendly techniques to control insect pests that are damaging to public health
Run 3DUsing advanced gait analysis to help understand the root-cause of injury in runners and provide long-term solutions
TΔSDeveloping ketone bodies as medical foods to increase physical and mental performance

Industrial applications / cleantech

Company Nature
Kepler EnergyTidal energy power using innovative transverse horizontal axis turbine
NavetasSmart electricity meter offering fully itemised energy billing
Oxbridge PulsarsData communications systems using polarization synchrotron technology
Oxford Biotrans Produce high-value chemicals using patented enzyme technology
Oxford PhotoVoltaics Organic solar cells for building integrated photovoltaics (BIPV)
SalundaDesigns non-contact electromagnetic sensors based on patented RF technology
OxonicaNanomaterials company with interests in fuel additives, diagnostics, materials and security
Oxford Imaging Detectors Development of high performance scientific imaging detectors capable of studying structures and processes at the atomic level
Oxford Multi Spectraldevelops and manufacturers Multi Spectral Scanners based upon a patented flatbed scanner design.
Yasa MotorsBreak through high power-to-weight motors
OXEMSElectromagnetic tagging and detection system for location of buried utilities
OxyntixDeveloping and commercialising new technologies in energy and process engineering
back to top

Other technology (inc. software)

Company Nature
MinervationSoftware and web site developer - Specialises in producing and disseminating accessible, usable and reliable health information
Oxford AncestorsDNA-based services for personal ancestry research anywhere in the world
SemmleDevelopment of novel query languages and environments for complex hierarchical data such as the source of software systems
Oxford Consultants for Social InclusionConsultancy based on deprivation indices
Oxford RiskRisk analysis services

Listed companies

Company Nature
AvactaDetection and analysis of biological materials and chemicals (AIM)
Oxford Advanced SurfacesDevelops and commercialises advanced materials and technology solutions using novel surface modification technology (AIM)
Oxford BiomedicaGene therapy and immunotherapy (LSE)
Oxford ImmunotecDiagnosis and monitoring of infection (initially TB)(NASDAQ)
SummitA range of drug discovery based on an Imino Sugar platform (AIM)
VelocysVelocys for use in production of clean fuels and other renewables (AIM)

To view companies that are no longer part of the portfolio please see the Exited Companies page.

back to top

Site Information

Institution
University of Oxford
Site
Oxford Spin-out Equity Management